Prostate cancer Board decisions

The veteran's appeal is remanded due to the need for additional development, including obtaining his VA treatment records and a VA examination. The claim will be reconsidered based on new evidence.

The veteran's claim for service connection for prostate cancer, which is claimed as secondary to exposure to ionizing radiation in service, has been remanded due to the need for updated dose information from DTRA.

The Board found no evidence of herbicide exposure and denied service connection for prostate cancer and Type II diabetes mellitus, as the conditions were not shown to be related to service or service-connected conditions.

The Board denied service connection for the claimed conditions, finding no evidence of such conditions during or after service and no link to herbicide exposure.

The veteran's 100% rating for postoperative carcinoma of the prostate has been reduced to 40%. The case is being remanded for further evaluation and clarification.

The veteran is seeking service connection for prostate cancer and a skin disorder, both potentially related to herbicide exposure during active duty. The case has been remanded due to the need for additional evidence and clarification of records.

The Board found no basis to establish service connection for prostate cancer due to in-service radiation exposure, and denied the claim. The veteran's post-traumatic stress disorder was not addressed as a separate issue.

The Board has determined that the veteran's claim for service connection for prostate cancer was not properly notified of its denial, and thus his effective date is October 30, 1998. The effective date for SMC due to loss of a creative organ is also set at October 30, 1998.

The Board found no credible evidence of the veteran's exposure to ionizing radiation during service, and thus denied his claim for service connection for prostate cancer due to such exposure.

The Board denied the veteran's claims for service connection for various conditions, including prostate cancer, residuals of excision of a lipoma of the right anterior chest wall, malaria, Hodgkin's disease, hypertension, coronary artery disease (CAD), and abdominal aortic aneurysm. The appeal is not about service connection at all.

The Board denied the veteran's claims for service connection for dorsal spine arthritis, prostate cancer (claimed secondary to left varicocele), and arthritis of both knees, lumbar spine, and sacroiliac joints. The appeals were not granted.

The Board denied the claim for service connection for the cause of the veteran's death, finding that there was no evidence linking the conditions that caused his death to service.

The Board denied service connection for prostate cancer due to exposure to ionizing radiation and also denied the claim based on accrued benefits purposes. The cause of death was not related to active service.

The Board found no evidence of a back disability during service or for decades thereafter, and thus denied the veteran's claim for service connection for low back disability. The prostate cancer claim is pending as it relates to exposure to ionizing radiation.

The RO denied the veteran's claim for a higher rating for his prostate cancer residuals and granted a noncompensable rating for his generalized anxiety disorder with depression.

The Board denied the veteran's claim of service connection for prostate cancer, as secondary to herbicide exposure (including Agent Orange), due to a lack of evidence showing exposure to such agents during his active duty in Thailand.

The RO has restored the veteran's disability rating for prostate cancer residuals from 100% to 20%, effective June 1, 2001. The decision also addressed a previous reduction of his disability rating.

The veteran's initial evaluation for his service-connected prostate cancer, status post radical prostatectomy was granted at a 20 percent rating in August 2002 and subsequently increased to 40 percent effective from May 20, 2002. The current evaluation of 40 percent is considered insufficient given the veteran's reported symptoms.

The Board denied the veteran's claims for service connection for prostate cancer, an immunodeficiency syndrome with chronic upper respiratory infections, sinusitis and bronchitis, peripheral neuropathy of both lower extremities, post-traumatic stress disorder, hearing loss, and tinnitus. The reasons were that there was no evidence to support a link between these conditions and the veteran's service or radiation exposure.

The Board found that Alzheimer's type dementia, a significant condition contributing to death, was not service-connected and denied the claim for cause of death. The DIC claim under 38 U.S.C.A. § 1318 also failed.